[Consultations in oncological supportive care mono-, multi-, ou interdisciplinary: What should we favour?].

Abstract:

:According to the point 7.6 and 7.7 of the Cancer Plan 2014, all cancer patients should have access to supportive care. Indeed, the supportive care consultation in oncology is an important tool for the symptom management of cancer patients at all times of treatment. This consultation can be mono-disciplinary or multi-disciplinary (with different professions: physician, nurse, psychologist, social service assistant…) with or without integration (multidisciplinary or interdisciplinary). There are few studies focusing on the types of consultations (mono- or multidisciplinary) to promote based on their expected outcomes. After describing the different types of consultations (initial, follow-up, unscheduled, discharge) and having highlighted the main issues of these consultations, we will present the possible configurations. Our discussion will concern then the advantages and disadvantages of monodisciplinarity and different types of multidisciplinary highlighting the possible improvements. At the end of this work, after a brief synthesis of the different outcomes associated with each type of consultation, we would like to discuss the type of consultation to choose according to the outcomes.

journal_name

Bull Cancer

journal_title

Bulletin du cancer

authors

Garnier SR,Pelletti C,Quenard C,Vallet F,Lemoine P,Guastella V,Rhondali W

doi

10.1016/j.bulcan.2015.04.019

subject

Has Abstract

pub_date

2015-09-01 00:00:00

pages

786-91

issue

9

eissn

0007-4551

issn

1769-6917

pii

S0007-4551(15)00159-9

journal_volume

102

pub_type

杂志文章,评审
  • [Technical considerations for KRAS testing in colorectal cancer. The biologist's point of view].

    abstract::Targeted therapy against the EGF receptor was shown to be effective in a subgroup of patients with KRAS wild-type colorectal cancer. Therefore, cetuximab (Erbitux) or panitumumab (Vectibix) obtained the authorization by the EMEA restricted to patients with KRAS wild-type tumours. KRAS mutational testing has become par...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2009.0996

    authors: Blons H,Laurent-Puig P

    更新日期:2009-12-01 00:00:00

  • [SOR SAVOIR PATIENT Cancer and fatigue. Information dedicated to cancer patients and relatives].

    abstract::In response to the evolution of the information-seeking behaviour of patients and concerns from health professionals regarding cancer patient information, the French National Federation of Comprehensive Cancer Centres (FNCLCC) introduced, in 1998, an information and education program dedicated to patients and relative...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Dielenseger P,Dilhuydy JM,Brusco S,Chazot L,Blay JY,Bové B,Colcanap B,Ferrandez JC,Floquet A,Jane Gledhill,Hubert N,Meslier M,Rosman S,Carretier J,Delavigne V,Fervers B,Leichtnam-Dugarin L,Philip T,Standards, Options

    更新日期:2006-12-01 00:00:00

  • [Schooling of young people with cancer].

    abstract::The schooling of young people with cancer poses various problems, similar to those experienced by disabled or chronically ill children. Published data on this subject in the medical literature comes mainly from studies carried out in the USA and the UK. Cancer and its treatment can cause both direct (learning difficul...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Vignes C,Godeau E,Bertozzi-Salamon AI,Vignes M,Grandjean H,Arnaud C

    更新日期:2007-04-01 00:00:00

  • Altered glucose metabolism in intact and tumor bearing rats subjected to local hyperthermia.

    abstract::Blood glucose levels were temporarily elevated in normal and in tumor bearing Lewis rats subjected to one local hyperthermic treatment in the leg or in the upper abdomen. Serum transferred from locally heated animals or serum heated in-vitro and injected to normal recipients resulted in elevated blood glucose levels. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Beer-Gabel M,Yerushalmi A

    更新日期:1981-01-01 00:00:00

  • [Respiratory sequellae after alternated chemotherapy and radiotherapy for small cell anaplastic cancer].

    abstract::The authors analyze the respiratory sequelae in 19 patients with limited small cell lung carcinoma who survived for more than 30 months following an alternating chemo-radiotherapeutic combined regimen. The clinical tolerance measured with respiratory functional test is acceptable. In two patients an effort dyspnea is ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: de Cremoux H,Baldeyrou P,Martin M,Ruffié P,Arriagada R,Le Chevalier T

    更新日期:1987-01-01 00:00:00

  • [Not Available].

    abstract::THE ROLE OF RUXOLITINIB IN THE TREATMENT OF MYELOPROLIFERATIVE NEOPLASMS: The discovery of the JAK2V617F mutation in 2005, present in 95% of polycythemia vera (PV) and in 55% of myelofibrosis (MF) patients, opened the way for a new era of targeted therapies for myeloproliferative neoplasms. Ruxolitinib was the first-i...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1016/S0007-4551(16)30143-6

    authors: Soret J,Kiladjian JJ

    更新日期:2016-06-01 00:00:00

  • [Prostate cancer: update].

    abstract::The study of mitotic transduction of the signal showed that overexpression of pAkt and reduction in pERK expression would be associated a biological relapse. For tumors T1-3 N0M0 at the high risk of local relapse after prostatectomy, an immediate radiotherapy compared with a differed radiotherapy (at the time of PSA r...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Oudard S,Medioni J,Scotté F,Banu E

    更新日期:2005-10-01 00:00:00

  • [Gliomas and BRCA genes mutations: fortuitous association or imputability?].

    abstract::BRCA is a tumor suppressor gene implicated in the major mechanisms of cellular stability in every type of cell. Its mutations are described in numerous cancers, mainly breast and ovarian in women. It was also found an increase of lifetime risk of pancreas, colon, prostate cancer or lymphoma in men carriers. We report ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2014.1952

    authors: Girardstein-Boccara L,Mari V,Met-Domestici M,Burel-Vandenbos F,Berthet P,Paquis P,Frenay MP,Lebrun-Frenay C

    更新日期:2014-09-01 00:00:00

  • [Medico-economical assessment in cancerology].

    abstract::In recent studies, the economic criteria has begun to be integrated to the appraisal in cancerology. The question asked by the economist can be framed as follows: what incremental cost should the collectivity or the health insurance system consent, in order to improve the care of cancer patients? This involves first t...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Lebrun T,Selke B,Bercez C,Bonneterre ME,Lenne X,Sailly JC,Bonneterre J

    更新日期:1997-05-01 00:00:00

  • [Invasive cervical cancer treatment costs in France].

    abstract::The objective of this study was to estimate the direct costs of invasive cervical cancer (ICC) management to the French national health insurance system the 1st year after ICC diagnosis. A retrospective survey was conducted in three centres in 2005, including 42 patients admitted for ICC between 2001-2003. Medical rec...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,多中心研究

    doi:

    authors: Arveux P,Bénard S,Bouée S,Lafuma A,Martin L,Cravello L,Rémy V,Breugelmans JG

    更新日期:2007-02-01 00:00:00

  • [Coordinated organization of symptoms management and support in all the stages of cancer disease: putting in place pluridisciplinary structures of supportive oncological care].

    abstract::The organization of the management of pain and other symptoms all along the cancer disease, of psychological support and palliative care is a complex question that does not correspond to any perfectly established model, both in France and abroad. Different structures are implied in there care and coexist with an insuf...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Krakowski I,Chardot C,Bey P,Guillemin F,Philip T

    更新日期:2001-03-01 00:00:00

  • [Importance of a multidisciplinary approach to metastatic cancer of the rectum].

    abstract::Management of rectal cancers with synchronous metastasis is difficult. We evaluated in 23 patients a combination of pelvic radiotherapy at the dose of 45 Gy in 5 weeks and 25 fractions with chemotherapy by 5-fluorouracil (350 mg/m2/day) and folinic acid (20 mg/m2/day) for 5 days at the time of the first and the fifth ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Mitry E,Pompili PL,Rougier P,Toma C,Ducreux M,Lusinchi A,Elias D,Fabri MC,Bourhis J,Kac J,Eschwege F,Lasser P

    更新日期:1998-08-01 00:00:00

  • [Experimental terato-carcinoma: behavior of embryoid bodies inoculated into the abdominal cavity of syngeneic mice].

    abstract::A suspension of CE "44" embryoïd-bodies obtained from a transplanted OTT 60-50 subline was injected into the abdominal cavity of syngeneic L 129 mice. Terato-carcinoma and ascitic fluid were produced the latter containing embryoïds. In situ examinations were made by serial transverse sectioning of the entire abdomen. ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Gaillard JA

    更新日期:1976-07-01 00:00:00

  • [Melanomas of the female genital tract: state of the art].

    abstract::Melanoma of the female genital tract is a rare location (less than 2% of melanomas all sites combined). These cancers have a very poor prognosis, due to the delay in diagnosis. Vulvar location is about 1% of melanomas then the vaginal location, uterine and ovarian. There is no consensus to date regarding their care, d...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1881

    authors: Trone JC,Guy JB,Mery B,Langrand Escure J,Lahmar R,Moncharmont C,Rivoirard R,Semay T,Chauleur C,Collard O,Vignot S,Magné N

    更新日期:2014-01-01 00:00:00

  • [Following communications made at American Society of Clinical Oncology 2010, what will change our practice? The point of view of the editorial board of Bulletin du Cancer].

    abstract::The congress of Asco made the object of numerous summaries of congress made in the heat of the moment and the Bulletin du Cancer decided to ask to his editorial board, a digested summary, at distance of the congress, to try to sum up the data of the congress which are going to change practice. Of the considerable numb...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1221

    authors: André T,Wislez M,Goncalves A,de La Motte Rouge T,Blay JY,Massard C,Bay JO,comité de rédaction du Bulletin du Cancer.

    更新日期:2010-12-01 00:00:00

  • [Gemcitabine and pemetrexed in genito-urinary tumors treatment].

    abstract::Among genito-urinary tumors, gemcitabine is indicated only for the treatment of locally advanced and metastatic urothelial cancer. The combination of gemcitabine and cisplatin is a new standard in this disease. Gemcitabine shows activity in refractory germ cell tumors. In salvage treatment its role is ongoing evaluati...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Fléchon A

    更新日期:2007-01-01 00:00:00

  • [Qualitative and collaborative research with cancer patients. Experience narratives of treatments for peritoneal carcinomatosis].

    abstract:UNLABELLED:This CORCAN study is concerned with the way patients hospitalised for peritoneal carcinosis perceive surgical treatment and hyperthermic intraperitoneal chemotherapy (HIPEC). OBJECTIVES:(1) To identify and analyse, using concepts of social representation and accounts of the illness, characteristics of the w...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2015.10.015

    authors: Durif-Bruckert C,Guilloux R,Guïoux A,Lasserre E,Goffette J,Régnier V

    更新日期:2016-02-01 00:00:00

  • [Immune-checkpoints: the new anti-cancer immunotherapies].

    abstract::The immune system plays a dual role against cancer: it prevents tumor cell outgrowth and also sculpts the immunogenicity of the tumor cells. Cancer cells are able to escape from the immune system by inhibiting T lymphocytes activation. New immunotherapies have been developped to target these T lymphocytes activation m...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:10.1684/bdc.2013.1771

    authors: Ileana E,Champiat S,Soria JC

    更新日期:2013-06-01 00:00:00

  • [Patients' information in percutaneous core breast biopsy].

    abstract::Information takes a large part of patient's perceptions of the procedure. If the information is adapted, patients tolerate the procedure well. We point out indications and explain the different types of procedure. For infraclinical masses, sonographically guided automated core needle biopsy removes samples. Sonographi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Barreau B,Tastet S,Lakdja F,Henriquès C,Valentin F,Labat MJ,Dilhuydy MH

    更新日期:2005-03-01 00:00:00

  • [Malignant cardiac tumors].

    abstract::Cardiac neoplasms are a rare occurrence in clinical practice. The various frequencies of primary and secondary malignant tumors vary from report to report, approximately 1% in most autopsy series and 4% in cancer patient's autopsies. Cardiac malignancies account for less 1% of cardiac surgery and about for 0.1% of car...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Debourdeau P,Gligorov J,Teixeira L,Aletti M,Zammit C

    更新日期:2004-11-01 00:00:00

  • [Evolution of the hospital pharmacies in public and private hospitals in the cancer network in Lorraine: Oncolor].

    abstract::With the objective of improvement of quality in oncology, an assessment of chemotherapy practice in hospital pharmacies in public and private hospitals was carried out by the regional committee of oncology in Lorraine. The 36 hospitals reporting using chemotherapy, had varied practices. The results of this survey lead...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: May I,Paulus C,Vigneron J,Watelet M,Veyrier B,Bichet F,Bideaux S,Bey P

    更新日期:2001-04-01 00:00:00

  • [Nomograms in routine clinical practice: Methodology, interest and limitations].

    abstract::In order to help the clinician, mathematical models including several clinical and pathological variables are proposed in the literature with the aim to predict the occurrence of an event of interest. Nomograms allow individual prognosis for each patient. When they are developed, validated and correctly used, nomogram...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2017.10.024

    authors: Filleron T,Chaltiel L,Jouve E,Cabarrou B,Gilhodes J,Lusque A,Mery E,Dalenc F,Martinez A

    更新日期:2018-01-01 00:00:00

  • [Use of alternative donors for allogeneic haematopoietic cell transplantation in lymphoid neoplasms: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)].

    abstract::Despite great improvements in the outcome of patients with lymphoma, some may still relapse or present with primary refractory disease. In these situations, allogeneic haematopoietic cell transplantation (allo-HCT) is a potentially curative option, in particular in the case of relapse after autologous stem cell transp...

    journal_title:Bulletin du cancer

    pub_type: 共识发展会议,杂志文章,实务指引,评审

    doi:10.1016/j.bulcan.2017.08.008

    authors: Gauthier J,Chantepie S,Bouabdallah K,Jost E,Nguyen S,Gac AC,Damaj G,Duléry R,Michallet M,Delage J,Lewalle P,Morschhauser F,Salles G,Yakoub-Agha I,Cornillon J

    更新日期:2017-12-01 00:00:00

  • [Value of detection of hormone receptors by biochemical and immunochemical methods in therapeutic decision for breast cancer].

    abstract::Receptor assays for both ER and PR in breast cancer specimens is used either to choose adjuvant therapy during the first treatment, or to choose hormone therapy for metastatic patients, or for the diagnosis of tumors. Whereas biochemical methods, either by radioligand or by monoclonal antibodies, have progressed over ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Goussard J

    更新日期:1996-12-01 00:00:00

  • [Informing the family: emotions and attitudes of oncogenetic counselees for familial breast/ovarian and/or colon cancer risk].

    abstract:BACKGROUND:Transmission of oncogenetic information (TOI) by probands to their families is of major importance to organize medical prevention in his family. Little is known about the difficulties that the proband faces when he tries to endorse his "duty to warn". METHODS:To characterize the barriers to TOI, a survey wa...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1016/j.bulcan.2014.09.001

    authors: Kwiatkowski F,Laquet C,Dessenne P,Bignon YJ

    更新日期:2015-02-01 00:00:00

  • An interim assessment of the experience of fast neutron boost in inoperable rectal carcinomas in Orléans.

    abstract::Since January 1981, 58 patients with postoperative recurrences or inoperable rectal cancer have been included in a trial featuring a neutron boost after an initial series of irradiation given by the classical high energy photon procedure. This group irradiated at the Neutrontherapy Unit in Orléans was compared to a hi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Breteau N,Destembert B,Favre A,Sabattier R,Schlienger M

    更新日期:1986-01-01 00:00:00

  • [Place of neoadjuvant treatments in oesophageal cancers care].

    abstract::Esophageal cancer has a poor prognosis. Recent epidemiological data has shown a modification of histologic types, as adenocarcinoma represents more than 50% of all patients newly diagnosed. Despite progress of surgery, overall survival at 5 years is still about 20% for resectable tumors, supporting the need for additi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章,评审

    doi:

    authors: Créhange G,Lorchel F,Bosset JF

    更新日期:2006-11-01 00:00:00

  • [Image guided radiation therapy (IGRT)].

    abstract::Image guided radiation therapy (IGRT) is a major technical innovation of radiotherapy. It allows locating the tumor under the linear accelerator just before the irradiation, by direct visualization (3D mode soft tissue) or indirect visualization (2D mode and radio-opaque markers). The technical implementation of IGRT ...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:10.1684/bdc.2010.1140

    authors: Lagrange JL,de Crevoisier R

    更新日期:2010-07-01 00:00:00

  • [Limitations of palliative chemotherapy, application to lung cancer: the point of view of hospital pharmacists].

    abstract::In our hospital, most of the patients with a cancer received palliative chemotherapy. Then, we wanted to know in which conditions these therapies were realised and most specially for patients with lung cancer. We noted the stage of the disease at the diagnosis, the median survival duration after diagnosis and the medi...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Demange C,Thiébaux I

    更新日期:2003-03-01 00:00:00

  • [Methodological and ethical quality in phase III cancer trials: role of the cooperative group].

    abstract::Phase III clinical trials (CT) are carried out more and more often in a multicentric way, under the aegis of one or more cooperative groups (CG). The goal of this study was to analyze the influence of the GC on ethical quality (EQ) and methodological quality (MQ) in phase III cancer CT. EQ (Berdeu-score) and MQ (Jadad...

    journal_title:Bulletin du cancer

    pub_type: 杂志文章

    doi:

    authors: Tuech JJ,Pessaux P,Moutel G,Thoma V,Schraub S,Hervé C

    更新日期:2004-10-01 00:00:00